AI Article Synopsis
- Angiotensin receptor neprilysin inhibitor is the standard treatment for adults with systolic heart failure and shows promise for other heart conditions.
- The study focuses on using this medication for children suffering from protein-losing enteropathy due to Fontan failure.
- The findings reflect the effectiveness and potential of this treatment in a pediatric population dealing with complex heart issues.
Article Abstract
Angiotensin receptor neprilysin inhibitor is the standard of care for systolic heart failure in adults. In addition, its use in adults with failing systemic right ventricles and diastolic heart failure is promising. This study reports our experience with this drug for protein-losing enteropathy secondary to Fontan failure in pediatrics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11225506 | PMC |
| http://dx.doi.org/10.1016/j.jaccas.2024.102395 | DOI Listing |
Publication Analysis
Top Keywords
protein-losing enteropathy
8
angiotensin receptor
8
receptor neprilysin
8
neprilysin inhibitor
8
heart failure
8
enteropathy failing fontan
4
failing fontan treatment
4
treatment angiotensin
4
inhibitor angiotensin
4
inhibitor standard
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!